glp 1 agonist review article GLP-1 Receptor Agonists: Effects on Glucose, Weight, and Cardiovascular Outcomes | Scott Isaacs, MD, FACP, FACE posted on the topic Glucagon-like peptide 1 receptor agonists:
Description
Before GLP-1 receptor agonists dominated diabetes care, DPP-4 inhibitors quietly laid the foundation for incretin-based therapy
Some investigators have characterized Alzheimer's disease as "type 3 diabetes" due to observed insulin resistance in the brain, though this terminology remains controversial and is not universally accepted
The relationship is always the same
Who taking a GLP-1 RA is not at increased risk of delayed gastric emptying when that is the very mechanism by which the drugs work
